High-resolution functional imaging with ultrasound contrast agents based on RF processing in an in vivo kidney experiment

Ultrasound in Medicine and Biology

Volumn 27, Issue 2, 2001, Pages 223-233

  Verbeek, Xander A A M ^a   Willigers, Jean M ^a   Prinzen, Frits W ^a   Peschar, Maaike ^a   Ledoux, Lón A F ^a   Hoeks, Arnold P G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Kidney perfusion; Perfusion assessment; RF processing; Ultrasound contrast agents

Indexed keywords

BIOLOGICAL ORGANS; DISEASES; IONIZING RADIATION; MEDICAL IMAGING; OPTIMIZATION; TISSUE; ULTRASONICS;

KIDNEY;

BIOMEDICAL ENGINEERING;

ECHO CONTRAST MEDIUM; SHU 508;

ANIMAL EXPERIMENT; ARTICLE; ARTIFACT; CONTRAST ENHANCEMENT; DOG; FEMALE; IMAGING; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY PERFUSION; NONHUMAN; PRIORITY JOURNAL; RADIOFREQUENCY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TECHNIQUE; TISSUE PERFUSION; ULTRASOUND;

ANIMALS; CONTRAST MEDIA; DOGS; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; KIDNEY; POLYSACCHARIDES; RADIO WAVES; REGIONAL BLOOD FLOW; RENAL CIRCULATION;

EID: 0035053446     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-5629(00)00318-5     Document Type: Article

References (65)

1. Positron emission tomography in cardiovascular disease
2. MR imaging of renal function
3. Measurement of renal perfusion and blood flow with fast computed tomography
4. Cardiac positron emission tomography
5. PET instrumentation; What are the limits?
6. Substraction procedure for the registration of tissue perfusion with Doppler ultrasound
7. Color and power Doppler imaging of the kidneys
8. Ultrasound contrast agents; Examples of blood pool agents
9. New ultrasound contrast agents and technological innovations
10. Assessment of regional myocardial perfusion with myocardial contrast echocardiography in a canine model of varying degrees of coronary stenosis
11. Report of the radionuclides in nephrourology committee for evaluation of transplanted kidney (review of techniques)
12. Renal perfusion; Pharmacologic changes depicted with power Doppler US in an animal model
13. Myocardial perfusion imaging in the setting of coronary artery stenosis and acute myocardial infarction using venous injection of a second-generation echocardiographic contrast agent
14. Ultrasound contrast agents; A review
15. Fractal analysis of renal cortical perfusion
16. Nuclear cardiology, part II; Scintigraphic evalution of cardiac function
17. SPECT and PET in the evaluation of coronary artery disease
18. Renal transplantation; The normal morphological and Doppler ultrasound examination
19. Quantification of myocardial perfusion with contrast echocardiography
20. Myocardial contrast echocardiography. 15 years of research and development
21. Assessment of regional myocardial blood flow with myocardial contrast two-dimensional echocardiography
22. Detection of coronary artery disease with myocardial contrast echocardiography
23. Multislice MRI in assessment of myocardial perfusion in patients with single-vessel proximal left anterior descending coronary artery disease before and after revascularization
24. Contrast echocardiography for assessment of myocardial perfusion
25. Quantification of global and regional renal blood flow with election beam computed tomography
26. MRI of myocardial infarction
27. Myocardial perfusion by contrast-enhanced echocardiography and dynamic contrast enhanced MR imaging
28. In vivo assessment of neovascularization of liver metastases using perfusion CT
29. Digital radiofrequency echocardiography in the detection of myocardial contrast following intravenous administration of Albunex
30. Contrast echocardiographic quantification of regional myocardial perfusion; Validation with an isolated rabbit heart model
31. Ultraschalldiagnostik der transplantatniere
32. Identification of hibernating myocardium; comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography
33. Magnetic resonance imaging evaluation of myocardial perfusion
34. Current role of contrast echocardiography in the diagnosis of cardiovascular diseases
35. Scintigraphic imaging of renal function
36. Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles
37. Myocardial contrast echocardiography for the assessment of coronary blood flow reserve; Validation in humans
38. The effect of ultrasound frame rate on perfluorocarbon-exposed sonicated dextrose albumin microbubble size and concentration when Insonifying at different flow rates transducer frequencies, and acoustic outputs
39. Increased ultrasound contrast and decreased microbubble destruction rates with triggered ultrasound imaging
40. Cortical blood-flow in the porcine kidney
41. Imaging instrumentation for ultrasound contrast agents
42. Developments in non-radioactive microsphere techniques for blood flow measurement
43. Regional renal blood flow in ewes
44. Regional renal blood flow in normal and diseased states
45. Diagnosis of renal artery stenosis; Feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate
46. Echo-enhancing agents; Their physics and pharmacology
47. Second harmonic ultrasonic blood perfusion measurement
48. Quantification of myocardial perfusion with myocardial contrast echocardiography during left atrial injection of contrast
49. Contrast ultrasonography for 2-D opacification of heart cavities, peripheral vessels, kidney and muscle
50. Renal cortical ischemia in rabbits revealed by contrast enhanced power Doppler sonography
51. Renal cortical perfusion in rabbits; Visualization with color amplitude imaging and an experimental microbubble-based US contrast agent
52. Destruction of contrast microbubbles during ultrasound imaging at conventional power output
53. Basis for detection of stenosis using venous administration of microbubbles during myocardial contrast echocardiography; Bolus or continuous infusion?
54. Interactions between microbubbles and ultrasound; In vitro and in vivo observations
55. Magnetic resonance first-pass myocardial perfusion imaging; Clinical validation and future applications
56. A feasibility study on quantitating myocardial perfusion with Albunex, an ultrasonic contrast agent
57. Contrast echocardiography
58. Measurement of the nonlinearity parameter B/A of contrast agents
59. Myocardial contrast echocardiography can be used to quentify intramyocardial blood volume